n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Adenoma in 7 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the primary adenoma cells and HT-29 cells in an attempt to know whether NaBT and two NSAIDs (aspirin and NS-398) could be used as effective adjuvant for reducing cell proliferation, and to explore the possible mechanisms therein involved." | 3.72 | [Effects of NaBT and NSAIDs on colorectal adenoma-carcinoma cells]. ( Gan, H; Ouyang, Q; Zhang, Z, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galamb, O | 1 |
| Spisák, S | 1 |
| Sipos, F | 1 |
| Tóth, K | 1 |
| Solymosi, N | 1 |
| Wichmann, B | 1 |
| Krenács, T | 1 |
| Valcz, G | 1 |
| Tulassay, Z | 1 |
| Molnár, B | 1 |
| Banu, NA | 1 |
| Daly, RS | 1 |
| Buda, A | 1 |
| Moorghen, M | 1 |
| Baker, J | 1 |
| Pignatelli, M | 1 |
| Zhang, Z | 1 |
| Ouyang, Q | 3 |
| Gan, H | 1 |
| Zhang, ZH | 1 |
| Gan, HT | 1 |
| Elder, DJ | 1 |
| Halton, DE | 1 |
| Crew, TE | 1 |
| Paraskeva, C | 1 |
| Yao, R | 1 |
| Rioux, N | 1 |
| Castonguay, A | 1 |
| You, M | 1 |
| Qiu, C | 1 |
7 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Adenoma
| Article | Year |
|---|---|
Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
Topics: Adenocarcinoma; Adenoma; Cluster Analysis; Colon; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; | 2010 |
Reduced tumour progression and angiogenesis in 1,2-dimethylhydrazine mice treated with NS-398 is associated with down-regulation of cyclooxygenase-2 and decreased beta-catenin nuclear localisation.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Apoptosis; beta Catenin; Bromodeoxyuridine; Carcinogens; Ce | 2011 |
[Effects of NaBT and NSAIDs on colorectal adenoma-carcinoma cells].
Topics: Adenocarcinoma; Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Butyrates; Cel | 2003 |
Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.
Topics: Adenoma; Apoptosis; Butyrates; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase Inhibitors; | 2004 |
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Carcinoma; Col | 2000 |
Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.
Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Chemoprevention; Cycl | 2000 |
[Study on the effect of COX-2's selective inhibitor on human colorectal adenoma cells proliferation].
Topics: Adenoma; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose | 2001 |